American Society of Hematology

Figure 2

Figure 2. Treatment-emergent adverse events (≥15% of patients) regardless of attribution.

Treatment-emergent adverse events (≥15% of patients) regardless of attribution.

This Feature Is Available To Subscribers Only

Sign In or Create an Account